Skip to main content

Advertisement

SpringerLink
Log in

Hodgkin’s Lymphoma Developed after Autologous Stem Cell Transplantation for Multiple Myeloma

Transformation or coincidental appearance?

  • Case Report
  • Published:
Pathology & Oncology Research

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Abbreviations

ABVD:

Doxorubicin 25 mg/m2, bleomycin 10 mg/m2, vinblastine 6 mg/m2, dacarbazine 375 mg/m2

Anti-SSA:

Anti-Sjögren’s syndrome A (SSA)

Anti-SSB:

Anti-Sjögren’s syndrome B (SSB)

ASCT:

Autologous stem cell transplantation

Bwkg:

Body weight kilogramm

CA 19–9:

Carbohydrate antigen 19–9

CD:

Cluster of differentiation

EBV:

Epstein-Barr virus

HL:

Hodgkin’s lymphoma

NHL:

Non-Hodgkin lymphoma

PET-CT:

Positron emission tomography—computed tomography

PTLD:

Posttransplant lymphoproliferative disorder

SCT:

Stem cell transplantation

VAD:

Vincristine 2 mg i.v., doxorubicin 9 mg/m2 i.v. és dexamethasone 40 mg

WHO:

World health organisation

References

  1. Curtis RE, Travis LB, Rowlings PA, et al. (1999) Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 94: 2208±2216.

  2. Lowe T, Bhatia S, Somlo G (2007) Second malignancies after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 13(10):1121–1134

    Article  PubMed  Google Scholar 

  3. Gy V, Sebestyén A, Járay J, Kopper L (2008) Malignant tumors in the immunocompromised state following organ transplantation. Orvosképzés 81:235–242

    Google Scholar 

  4. Fend F, Martinez A, Quintanilla-Martinez L et al (2002) Clonally unrelated Hodgkin’s disease following autologous stem cell transplant for B-cell lymphoma. Br J Haematol 116(2):329–333

    Article  PubMed  Google Scholar 

  5. Zambelli A, Lilleri D, Baldanti F, Scelsi M, Villani L, Da Prada GA (2005) Hodgkin’s disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma. BMC Cancer 23(5):109

    Article  Google Scholar 

  6. Ludwig H, Strasser-Weippl K, Schreder M, Zojer N (2007) Advances in the treatment of hematological malignancies: current treatment approaches in multiple myeloma. Ann Oncol 18(9):64–70

    Article  Google Scholar 

  7. Stojanoski Z, Georgievski B, Cevreska L et al (2008) Autologous stem-cell transplantation in patients with multiple myeloma. Prilozi 29(1):265–279

    PubMed  CAS  Google Scholar 

  8. Jaffe ES, Zarate-Osorno A, Medeiros J (1992) The interrelationship of Hodgkin’s disease and non-Hodgkin’s lymphomas—lessons learned from composite and sequential malignancies. Semin Diagn Pathol 9:297–303

    PubMed  CAS  Google Scholar 

  9. Brauninger A, Hansmann ML, Strickler JG, Dummer R, Burg G, Rajewsky K, Kuppers R (1999) Identification of common germinal-center B-cell precursors in two patients with both Hodgkin’s disease and non-Hodgkin’s lymphoma. N Engl J Med 340:1239–1247

    Article  PubMed  CAS  Google Scholar 

  10. Ohno T, Smir BN, Weisenburger DD, Gascoyne RD, Hinrichs SD, Chan WC (1998) Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukemia with Hodgkin’s transformation. Blood 91:1757–1761

    PubMed  CAS  Google Scholar 

  11. Rowlings PA, Curtis RE, Passweg JR et al (1999) Increased incidence of Hodgkin’s disease after allogeneic bone marrow transplantation. J Clin Oncol 17(10):3122–3127

    PubMed  CAS  Google Scholar 

  12. Ranganathan S, Webber S, Ahuja S, Jaffe R (2004) Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma? Pediatr Dev Pathol 7(4):348–360

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

ASz participated the daily practice, LV carried out the follow-up, MZ performed the coordination of diagnosis and therapy and the revision of the manuscript. GM performed the pathological analyses.

Competing Interests

The author(s) declare that they have no competing interests.

Author information

Authors and Affiliations

  1. 3rd Department of Internal Medicine, University of Debrecen Medical and Health Science Center, Móricz Zs. krt. 22, 4032, Debrecen, Hungary

    Istvan Kulcsar, Antonia Szanto, Laszlo Varoczy & Margit Zeher

  2. Institute for Pathology, University of Debrecen Medical and Health Science Center, Nagyerdei krt. 98, 4032, Debrecen, Hungary

    Gabor Mehes

Authors
  1. Istvan Kulcsar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonia Szanto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laszlo Varoczy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gabor Mehes
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Margit Zeher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Istvan Kulcsar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kulcsar, I., Szanto, A., Varoczy, L. et al. Hodgkin’s Lymphoma Developed after Autologous Stem Cell Transplantation for Multiple Myeloma. Pathol. Oncol. Res. 18, 733–736 (2012). https://doi.org/10.1007/s12253-011-9477-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-011-9477-5

Keywords

Search

Navigation